Tag | Content |
---|
EnhancerAtlas ID | HS051-11535 |
Organism | Homo sapiens |
Tissue/cell | Fetal_thymus |
Coordinate | chr17:28008680-28011350 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr17:28009684-28009702 | GGAAGGCAGGCAGGCAAG | + | 6.45 | EWSR1-FLI1 | MA0149.1 | chr17:28009692-28009710 | GGCAGGCAAGAAGGAAGG | + | 6.49 | EWSR1-FLI1 | MA0149.1 | chr17:28009672-28009690 | TGAAAGAAGGAAGGAAGG | + | 7.85 | EWSR1-FLI1 | MA0149.1 | chr17:28009696-28009714 | GGCAAGAAGGAAGGAAGG | + | 7.87 | EWSR1-FLI1 | MA0149.1 | chr17:28009676-28009694 | AGAAGGAAGGAAGGCAGG | + | 8.16 | EWSR1-FLI1 | MA0149.1 | chr17:28009680-28009698 | GGAAGGAAGGCAGGCAGG | + | 9.02 | NFAT5 | MA0606.1 | chr17:28009381-28009391 | AATGGAAAAT | - | 6.02 | NFATC1 | MA0624.1 | chr17:28009381-28009391 | AATGGAAAAT | - | 6.02 | NFATC3 | MA0625.1 | chr17:28009381-28009391 | AATGGAAAAT | - | 6.02 | SP3 | MA0746.2 | chr17:28010471-28010484 | CGCCCCGCCCACC | + | 6.14 |
|
| Number of super-enhancer constituents: 16 | ID | Coordinate | Tissue/cell |
SE_00091 | chr17:28008199-28012343 | Adipose_Nuclei | SE_04346 | chr17:28008697-28011336 | Brain_Anterior_Caudate | SE_05391 | chr17:28008606-28010878 | Brain_Cingulate_Gyrus | SE_07345 | chr17:28008386-28011023 | Brain_Hippocampus_Middle_150 | SE_08600 | chr17:28008692-28010340 | Brain_Inferior_Temporal_Lobe | SE_09243 | chr17:28007579-28011162 | CD14 | SE_10996 | chr17:28008103-28012533 | CD20 | SE_18775 | chr17:28008405-28010526 | CD4p_CD25-_Il17-_PMAstim_Th | SE_30972 | chr17:28008419-28011082 | Fetal_Thymus | SE_41508 | chr17:28009041-28011236 | Left_Ventricle | SE_43139 | chr17:28009234-28011103 | Lung | SE_48078 | chr17:28009018-28011294 | Psoas_Muscle | SE_51084 | chr17:28008609-28010633 | Skeletal_Muscle | SE_54418 | chr17:28008995-28011274 | Spleen | SE_58538 | chr17:28008486-28106930 | Ly1 | SE_62296 | chr17:28008388-28106801 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr17 | 28009886 | 28010651 | chr17 | 28008780 | 28011200 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH17I029681 | chr17 | 28008459 | 28011295 |
|
Enhancer Sequence | TTATTAAAAT ATAACATAAT ACTCAAAGAA CTTGTAAATG GGCTAAATGA ATTGGCTGCA 60 ACGTATTATT AAGAACTATT TGTACTTGTC ATAATCTGGG TTCCACTTTG GCTTAATACT 120 ATTTTGAAGC ATTAACATTT ACATTCTCAG ATATGAAATG ATACAAATTC AAATTCCTTC 180 AACAACAACT GAGACAGAAA TGATTTTAGA TTACCTGAGC ATCTGAGACT TCTTACTGTC 240 CAAGGAACTC ATTAAAGCAG AGGATGTATG GGAATTTCAT AATAGCAAGT TTAGCAAACA 300 GAATGAAAAC TAGTTTCTAG CTTTTCATGT TTTAAGTTTG TCTTCTATAA ACTATAATTT 360 CCTTTGGCTA GTGACACTGG TCAGATATGA TTCAGACAGG GCCATTGGCA AAAGATAGAT 420 GTAATTTACT GAGTATAAAC TACTGGATAC CTATATTAAT ATGCATTCTT TCTGGTAAAG 480 TTTAGGACAA AGTGAAAGAG AAATGATTAG ACATGTGCTT GCTCATATTC TGGGTCAGGA 540 GAATCTGCAG TTATTGTCTT CTGTCTCTAG GGGAAGATTC AATTGAAGCT TCATGAGGTT 600 CCTGTTCCTG TTTTATAGGG TTTTCAAGGG AGGGGGTCAG GGAGAACTGA ACAAAGGAAA 660 TATGAGCTAG AACAGTGCTG TCCAACTGAA CTTTCTGCAA GAATGGAAAA TGTTCTATAC 720 ATGTACTGTC TAATACGATA GCCACTAGCA CATACGGTTA CTGAATACTT GAAATGTGAC 780 TAGTTAGAAC TGAGGAATTG AAATTTCATT TAATTTTAAT CTATTTAAAA AGACACGTGC 840 ATGCTGTATG CAGTGGCTCA TGCCTATAAT CCCAGCACTC AGGAAGGCAG AGGCAGGAGC 900 TCAGGAGTTG AGACCAGCCT GGGCAACACA GAGAGACTGT GTTCTTCACA AAAAGGAAAA 960 AAGAAAAGAA GAGAAGAGAA AAGGAAGGAA GATGAAAGAA GGAAGGAAGG CAGGCAGGCA 1020 AGAAGGAAGG AAGGGGCACA TATGGTTAGT GGCTACTATA CTGGACAACA CAGATCTAGA 1080 AAGATTAAAA ACCTAAATTA GAGGTCCTAA AATCCTAATG AATGTAAACA AGGTAGGTGC 1140 TGTTATAGGA AAATGCTTAC TGAAAGCTCT GTTGCTTAAT CAGAAGTTAA AACCATGCAG 1200 GAGAAATCTT CCTAAATCTG GTTTACAAGC CTGTGTAAAT TCAGAGCCTA CAATTAAATG 1260 CTGTTAAGTG GTATACAAGC TAATAACTTT GGCTTTGGGA ATTCCTGTGA ACCCCCAAGT 1320 CATTTTCAGG TTGACTTCTA TATAGGAATA AGGTAAACAT TGGTTTGGGA AACTTTCTAG 1380 TGACAAAGTG ATTTTTTCCC CTCAACATCA GGAAAATTAG AATCATTCCC AGGCTCCTCC 1440 TCTCTTTGTG GCTAAATTTC CCTAGGCCTG GGTCACACCC CTAGCTACCC CATAGTTCCA 1500 TTCTAATCCT GAACCAGGAA GTCAATGCTT TGAGACATCT GGCAGGATTT CCTGAGGCTA 1560 ATTATCCACA GCGTAAAGAT CTGCTTAGCA GCCACATTCC AAAGTCTTCC GAAGGTTTCT 1620 CCAGAAAAAG TGGGAAAAAT AAAAAAGGAA AGCAACAAAC CTTAAGGACA CACGAAAAGG 1680 CCAGGTGTTG TGTGTCATCT TTCATCATAG AATGTAAAGT ACAGCTAAAG CCAAAGGTAC 1740 ATAAAAAGTT CTGCTTTGAG TTTAAGGAGC CATCCCGTAC CACCCCATCC CCGCCCCGCC 1800 CACCATCCTT TTTAACTCAA TAGAAGGAAA AAGGAGGCAT AGCATTTGGT AAAAGCAAGG 1860 TTTAAACAAA ACAGACTGTA GTTTAAGTGG GATCTCTTTG TATCTGGGAC TACTGGTATA 1920 CTACCACAAA GGGTAGGTGC CCTAGAATCA CCAAAGTGAA TCATTACTGA CTACAATAGA 1980 GTAGGCCAGG TGCAAGGCTC ATGCCTGTAA TCCCAGCACT TTGGGAAGCC GAAGTGGGAG 2040 GATTGCTTAA GCCCAAGAAT TCAAGACCAG CCTGGCCAAC ATAAGGAAAT CTTCTCTCCA 2100 GAAAAATAAG GAAAAAAAAA AAAAAAAGAC CAAATAGCTG GGTATGGTGG TGCATGCCTG 2160 TACTTCTAGC TACTTAGGAG GCTGAGGTGG AAGGATTCCT AGAGCCCAGG AGGAATTTGA 2220 GGCCGTAGTG AGCTGTGACT GCATCACGGC ACTTCAGCCT GGGCAGCAGA GCGAGACGCT 2280 GTCTCAAAAA GAGAAATAAA AAGGCAGCTT TTTTTCCATG GAAATGTAAC TTTGAAACCA 2340 CTTGCTTTAT ATTGTGACTA TCTAAAGATG AGATGAAGGT ATGGAATAAT GGTAAATTGG 2400 AAACACACGA CCAAAGACAT TCACTAAACA TTCTTGTTTC TCAAGACTGT GGCTAAGATA 2460 CTTATGTTCT TTAGTTTTAT GTCTTGTACT TTAACAGCAG AACTGCACAA GATATTTTTG 2520 TGATAAAAGG CAACTGGGGC CAGGCACGGT GGCTCACGCC TGTAATCTCA GTACTTTGGG 2580 AGGCTGAGGT GGGTGGATCA CTTGAGGTCA GGAGTTTGAA ACTGGCCAAT ATGGCAAAAC 2640 CCCATCTCTA CTAAAAATAC AAAAATTAGT 2670
|